However, since hypoglycemia is harmful to septic patients, glycemic control by intensive insulin therapy is not the current trend in sepsis management, and a typical target blood glucose range is set at 144–180 mg/dL (Recommendation 69) [6]. The gene discussed is INS; the disease is Sepsis.